Skip to main content

Tak Jeong

Yonsei University · 医学

研究室紹介

Professor Tak Jeong's research lab specializes in the molecular and pathological characterization of primary liver cancers, with a focus on intrahepatic cholangiocarcinoma (iCCA) and hepatocellular carcinoma (HCC). The lab investigates the histopathological, genomic, and transcriptomic heterogeneity of these malignancies, aiming to identify distinct subtypes based on differentiation markers, genetic alterations, and radiopathologic features. Key research directions include the classification of iCCA subtypes—particularly small duct type with cholangiolocellular differentiation or DPM (ductal-predominant morphology)—and the identification of prognostic biomarkers such as PHH3, LOXL2, FGFR, and ARID1A variants. The lab integrates multi-omics data with clinical and imaging profiles to improve diagnostic accuracy and patient stratification in liver cancer.

intrahepatic cholangiocarcinomahepatocellular carcinomamolecular subtypesprognostic biomarkerstranscriptomic profiling

Research Overview

Papers
48
Total Citations
627
Papers (5y)
29
Primary Field
医学

Research Output Trend

Figures are computed from collected data and may differ slightly.

Publications per year (5y)
29total
2022
2023
2024
2025
2026
Citations per year (5y)
207total
20222023202420252026

Selected Papers

15
1
Article|115 citations·2017
The value of phosphohistone H3 as a proliferation marker for evaluating invasive breast cancers: A comparative study with Ki67
Ji‐Ye Kim, Hyang Sook Jeong, Taek Chung, Moonsik Kim, Ji Hee Lee, Woo Hee Jung, Ja Seung Koo
SJR Q2OncotargetOA

Poor reproducibility and inadequate representation of proliferation of Ki67 and MAI may be improved by PHH3, allowing better accuracy in breast cancer diagnostics.

Cancer ResearchBiochemistry, Genetics and Molecular Biology
2
Review|78 citations·2022
Up-to-Date Pathologic Classification and Molecular Characteristics of Intrahepatic Cholangiocarcinoma
Taek Chung, Young Nyun Park
SJR Q1Frontiers in MedicineOA

Intrahepatic cholangiocarcinoma (iCCA) is an aggressive primary liver malignancy with an increasing incidence worldwide. Recently, histopathologic classification of small duct type and large duct type iCCA has been introduced. Both these types of tumors exhibit differences in clinicopathological features, mutational profiles, and prognosis. Small duct type iCCA is composed of non-mucin-producing cuboidal cells, whereas large duct type iCCA is composed of mucin-producing columnar cells, reflectin

SurgeryMedicine
3
Article|55 citations·2017
Transcriptomic and histopathological analysis of cholangiolocellular differentiation trait in intrahepatic cholangiocarcinoma
Hyungjin Rhee, Jung Eun Ko, Taek Chung, Byul A Jee, So Mee Kwon, Ji Hae Nahm, Jae Yeon Seok, Jeong Eun Yoo, Jin‐Sub Choi, Snorri S. Thorgeirsson, Jesper B. Andersen, Hye Sun Lee
SJR Q1Liver InternationalOA

BACKGROUND & AIMS: Intrahepatic cholangiocarcinoma (iCCA) is a heterogeneous entity with diverse aetiologies, morphologies and clinical outcomes. Recently, histopathological distinction of cholangiolocellular differentiation (CD) of iCCA has been suggested. However, its genome-wide molecular features and clinical significance remain unclear. METHODS: Based on CD status, we stratified iCCAs into iCCA with CD (n=20) and iCCA without CD (n=102), and performed an integrative analysis using transcrip

SurgeryMedicine
4
Article|46 citations·2020
Gross type of hepatocellular carcinoma reflects the tumor hypoxia, fibrosis, and stemness-related marker expression
Hyungjin Rhee, Taek Chung, Jeong Eun Yoo, Ji Hae Nahm, Ha Young Woo, Gi Hong Choi, Dai Hoon Han, Young Nyun Park
SJR Q1Hepatology InternationalOA
HepatologyMedicine
5
Article|46 citations·2022
Molecular and radiopathologic spectrum between HCC and intrahepatic cholangiocarcinoma
Youngsic Jeon, So Mee Kwon, Hyungjin Rhee, Jeong Eun Yoo, Taek Chung, Hyun Goo Woo, Young Nyun Park
SJR Q1HepatologyOA

BACKGROUND AND AIMS: Primary liver cancers (LCs), including HCC and intrahepatic cholangiocarcinoma (iCCA), are derived from a common developmental lineage, conferring a molecular spectrum between them. To elucidate the molecular spectrum, we performed an integrative analysis of transcriptome profiles associated with patients' radiopathologic features. APPROACH AND RESULTS: We identified four LC subtypes (LC1-LC4) from RNA-sequencing profiles, revealing intermediate subtypes between HCC and iCCA

SurgeryMedicine
6
Article|34 citations·2019
Clinicopathological characteristics of intrahepatic cholangiocarcinoma according to gross morphologic type: cholangiolocellular differentiation traits and inflammation- and proliferation-phenotypes
Taek Chung, Hyungjin Rhee, Ji Hae Nahm, Youngsic Jeon, Jeong Eun Yoo, Young‐Joo Kim, Dai Hoon Han, Young Nyun Park
SJR Q1HPBOA
SurgeryMedicine
7
Article|28 citations·2021
Genetic, Clinicopathological, and Radiological Features of Intrahepatic Cholangiocarcinoma with Ductal Plate Malformation Pattern
Taek Chung, Hyungjin Rhee, Hyo Sup Shim, Jeong Eun Yoo, Gi Hong Choi, Haeryoung Kim, Young Nyun Park
SJR Q1Gut and LiverOA

iCCAs with DPM pattern have different clinico-radio-pathologic and genetic characteristics compared to conventional iCCAs. Moreover, <i>FGFR</i> and <i>ARID1A</i> variants were identified. Altogether, these findings further suggest that iCCA with DPM pattern represents a specific subtype of small duct type iCCA.

SurgeryMedicine
8
Article|27 citations·2018
Increased Expression of the Matrix-Modifying Enzyme Lysyl Oxidase-Like 2 in Aggressive Hepatocellular Carcinoma with Poor Prognosis
Jiwoon Choi, Taek Chung, Hyungjin Rhee, Young‐Joo Kim, Youngsic Jeon, Jeong Eun Yoo, Songmi Noh, Dai Hoon Han, Young Nyun Park
SJR Q1Gut and LiverOA

LOXL2 expression represents a subgroup of HCCs with more aggressive behavior and is suggested to be a poor prognostic marker in HCC patients.

Molecular BiologyBiochemistry, Genetics and Molecular Biology
9
Article|27 citations·2021
YAP inactivation in estrogen receptor alpha-positive hepatocellular carcinoma with less aggressive behavior
Youngsic Jeon, Jeong Eun Yoo, Hyungjin Rhee, Young‐Joo Kim, Gwang Il Kim, Taek Chung, Sarah Yoon, Boram Shin, Hyun Goo Woo, Young Nyun Park
SJR Q1Experimental & Molecular MedicineOA

The expression of estrogen receptor alpha (ERα, encoded by ESR1) has been shown to be associated with the prognostic outcomes of patients in various cancers; however, its prognostic and mechanistic significance in hepatocellular carcinoma (HCC) remain unclear. Here, we evaluated the expression of ERα and its association with clinicopathological features in 339 HCC patients. ERα was expressed in 9.4% (32/339) of HCCs and was related to better overall survival (OS; hazard ratio [HR] = 0.11, p = 0.

Cell BiologyBiochemistry, Genetics and Molecular Biology
10
Article|21 citations·2018
Stromal p16 Overexpression in Gastric-type Mucinous Carcinoma of the Uterine Cervix
Taek Chung, Sung‐Im Do, Kiyong Na, Geon Kim, Young In Jeong, Youn Wha Kim, Hyun Soo Kim
SJR Q2Anticancer ResearchOA

Stromal p16 expression of MC-G was significantly higher than that of normal cervix and other histological subtypes of adenocarcinoma and was associated with advanced stage, parametrial invasion, and lymphovascular invasion, reflecting the aggressive behavior of MC-G. Our observations suggest that stromal p16 expression is involved in the development and progression of MC-G.

Pulmonary and Respiratory MedicineMedicine
11
Article|20 citations·2024
Artificial Intelligence-Powered Spatial Analysis of Tumor-Infiltrating Lymphocytes as a Potential Biomarker for Immune Checkpoint Inhibitors in Patients with Biliary Tract Cancer
Yeong Hak Bang, Choong‐kun Lee, Kyunghye Bang, Hyung‐Don Kim, Kyu‐pyo Kim, Jae Ho Jeong, Inkeun Park, Baek‐Yeol Ryoo, Dong Ki Lee, Hye Jin Choi, Taek Chung, Seung Hyuck Jeon
SJR Q1Clinical Cancer ResearchOA

PURPOSE: Recently, anti-programmed cell death-1/anti-programmed cell death ligand-1 (anti-PD1/L1) immunotherapy has been demonstrated for its efficacy when combined with cytotoxic chemotherapy in randomized phase 3 trials for advanced biliary tract cancer (BTC). However, no biomarker predictive of benefit has been established for anti-PD1/L1 in BTC. Here, we evaluated tumor-infiltrating lymphocytes (TIL) using artificial intelligence-powered immune phenotype (AI-IP) analysis in advanced BTC trea

SurgeryMedicine
12
Article|18 citations·2018
Recapitulation of pharmacogenomic data reveals that invalidation of SULF2 enhance sorafenib susceptibility in liver cancer
Sarah Yoon, Eun‐Ju Lee, Ji Hye Choi, Taek Chung, Do Young Kim, Jong-Yeop Im, Myung-Ho Bae, Jung‐Hee Kwon, Hyuk-Hoon Kim, Hyung Chul Kım, Young Nyun Park, Hee-Jung Wang
SJR Q1Oncogene
HepatologyMedicine
13
Article|16 citations·2020
Significance of Radial Margin in Patients Undergoing Complete Mesocolic Excision for Colon Cancer
Jong Min Lee, Taek Chung, Kyung Min Kim, Ng Siu Man Simon, Yoon Dae Han, Min Soo Cho, Hyuk Hur, Kang Young Lee, Nam Kyu Kim, Sat Byol Lee, Ga Ram Kim, Byung Soh Min
SJR Q2Diseases of the Colon & RectumOA

BACKGROUND: Comparable to circumferential resection margin in rectal cancer, radial margin is a potential prognostic factor in colon cancer that has just begun to be studied. No previous studies have investigated the influence of radial margin in the context of complete mesocolic excision. OBJECTIVE: This study aimed to examine the impact of radial margin on oncologic outcomes after complete mesocolic excision for colon cancer. DESIGN: We retrospectively reviewed patients with stage I to III col

OncologyMedicine
14
Article|13 citations·2019
Multimodality imaging studies of intraductal tubulopapillary neoplasms of the pancreas
Hye Jin Kim, Mi‐Suk Park, Taek Chung, Bohyun Kim, Jei Hee Lee, Jai Keun Kim
SJR Q2Diagnostic and Interventional RadiologyOA

PURPOSE: We aimed to investigate multimodality imaging findings of intraductal tubulopapillary neoplasms (ITPN) of the pancreas. METHODS: This study was approved by the institutional review board with waived informed consent. A total of eight patients were histopathologically diagnosed with pancreatic ITPN in a single institution over a 6-year period. The imaging findings of dynamic contrast-enhanced computed tomography (CT), magnetic resonance cholangiopancreatography (MRCP), endoscopic ultraso

OncologyMedicine
15
Article|12 citations·2022
PSMA Immunohistochemistry in Hepatic Neoplasms
Michel Kmeid, Young Nyun Park, Taek Chung, Georgi Lukose, Luz Sullivan, Rupinder Brar, Hwajeong Lee
SJR Q1The American Journal of Surgical PathologyOA

Accurate classification of well-differentiated hepatocellular neoplasms can be challenging especially in core biopsies. Prostate-specific membrane antigen (PSMA) has been shown to highlight tumor-associated neovasculature in many nonprostatic solid tumors including hepatocellular carcinoma (HCC). Archived 164 hepatectomies and explants with 68 HCCs, 31 hepatocellular adenoma (HA), 24 dysplastic nodules (DN), and 42 metastases were retrieved, and pathologic parameters were evaluated. Sensitivity,

Pulmonary and Respiratory MedicineMedicine

Research Areas

SurgeryOncologyPulmonary and Respiratory MedicineHepatologyMolecular BiologyCell Biology

Tak Jeongの研究をNubintでさらに深く

この研究室の論文をアプリで開き、AIと共に読み、要約し、引用しましょう。